Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|July 15, 2022
Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinomaKefan Zhou, Jin Zhao, Hongjuan Xu, et al.
ACS Pharmacology & Translational Science|May 14, 2026
A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination TherapiesNing Shi, Jie Wang, Can Xu, et al.
Frontiers in Oncology|January 11, 2021
Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and PrognosisQuanwei Zhou, Xuejun Yan, Weidong Liu, et al.
Frontiers in Immunology|November 29, 2023
A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patientsYi Zhou, Wen Yin, Yirui Kuang, et al.
Frontiers in Immunology|December 15, 2022
PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacyNing Shi, Yangyihua Zhou, Yujun Liu, et al.
Neoplasia (New York, N.Y.)|October 19, 2005
Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissuesLiang Zhou, Weihong Jiang, Caiping Ren, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2025
ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in gliomaXuejun Yan, Rongnian Li, Jing Xu, et al.
Molecular Biotechnology|March 11, 2008
Lipofectamine RNAiMAX: an efficient siRNA transfection reagent in human embryonic stem cellsMing Zhao, Hong Yang, Xingjun Jiang, et al.
Signal Transduction and Targeted Therapy|November 14, 2020
Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinomaYuanbo Kang, Weihan He, Caiping Ren, et al.
Frontiers in Pharmacology|September 12, 2022
Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade gliomaYudong Cao, Hecheng Zhu, Quan Chen, et al.
Pageof 10